Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unexplored pharmacokinetic opportunities with microdosing in oncology.

× No keyword cloud information.

6 in total

1. Propargyl 4-[F]fluorobenzoate: A Putatively More Stable Prosthetic group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry.

Authors: Ganesan Vaidyanathan; Benjamin J White; Michael R Zalutsky
Journal: Curr Radiopharm Date: 2009-01-01

2. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.

Authors: Dietmar Schwab; Agnes Portron; Zoe Backholer; Berthold Lausecker; Kosuke Kawashima
Journal: Clin Pharmacokinet Date: 2013-06 Impact factor: 6.447

3. Quantifying Carbon-14 for Biology Using Cavity Ring-Down Spectroscopy.

Authors: A Daniel McCartt; Ted J Ognibene; Graham Bench; Kenneth W Turteltaub
Journal: Anal Chem Date: 2016-08-09 Impact factor: 6.986

Review 4. Microdosing and drug development: past, present and future.

Authors: Graham Lappin; Robert Noveck; Tal Burt
Journal: Expert Opin Drug Metab Toxicol Date: 2013-04-04 Impact factor: 4.481

5. Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient.

Authors: James H Doroshow; Ralph E Parchment
Journal: Clin Cancer Res Date: 2008-06-15 Impact factor: 12.531

6. Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug.

Authors: Dong Ki Kim; Jay Wook Lee; Kwang-Hee Shin; Sejoong Kim; Kook-Hwan Oh; Myounghee Kim; Kyung-Sang Yu; Jung Pyo Lee; Chun-Soo Lim; Yon Su Kim; Kwon Wook Joo
Journal: BMC Nephrol Date: 2014-03-17 Impact factor: 2.388

6 in total